Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-11-053138
Filing Date
2011-11-14
Accepted
2011-11-14 11:54:19
Documents
2
Group Members
AYER CAPITAL PARTNERS MASTER FUND, L.P.AYER CAPITAL PARTNERS, LLC

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G 126227
2 MISCELLANEOUS EXHIBITS misc1.htm EX-1.1 11391
  Complete submission text file 0001140361-11-053138.txt   139397
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-33655 | Film No.: 111199547
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 CALIFORNIA, SUITE 600 SAN FRANCISCO CA 94111
Business Address 230 CALIFORNIA, SUITE 600 SAN FRANCISCO CA 94111 4158744800
Ayer Capital Management, LP (Filed by) CIK: 0001471149 (see all company filings)

EIN.: 262134101 | State of Incorp.: DE | Fiscal Year End: 1209
Type: SC 13G